Active fixation of bipolar left ventricular lead through a persistent left superior vena cava

Daniele Nicolis1, Giacomo Mugnai2, Patrizia Pepi1

  • 1Division of Cardiology Carlo Poma Hospital, ASST Mantova Mantova Italy.

Insights

A persistent left superior vena cava was identified in a patient with severe heart dysfunction. Cardiac resynchronization therapy with a defibrillator (CRT-D) was successfully implanted despite this rare congenital anomaly.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Electrophysiology

Background:

  • Persistent left superior vena cava (PLSVC) is a rare congenital anomaly of the thoracic venous system.
  • Dilated and hypokinetic cardiomyopathy with severe left ventricular dysfunction presents significant challenges for cardiac device implantation.
  • Valvular heart disease can further complicate cardiac management and device selection.

Purpose of the Study:

  • To report a case of successful cardiac resynchronization therapy with a defibrillator (CRT-D) implantation in a patient with a persistent left superior vena cava.
  • To highlight the management of a challenging congenital cardiac venous anomaly in the context of severe left ventricular dysfunction.

Main Methods:

  • Diagnosis of persistent left superior vena cava via imaging (details not specified in abstract).
  • Coronary angiography to rule out ischemic heart disease.
  • Implantation of a biventricular defibrillator device (CRT-D).

Main Results:

  • A 61-year-old patient with dilated cardiomyopathy, severe left ventricular dysfunction (LVEF 32%), and valvular disease was found to have a persistent left superior vena cava.
  • Coronary angiography was negative for obstructive coronary artery disease.
  • Successful implantation of a CRT-D device was achieved.

Conclusions:

  • Cardiac resynchronization therapy with a defibrillator can be successfully implanted in patients with persistent left superior vena cava and severe left ventricular dysfunction.
  • This case demonstrates the feasibility of managing complex congenital venous anomalies during cardiac device implantation.